Young HIV-infected children and their adult caregivers prefer tablets to syrup antiretroviral medications in Africa

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Nahirya Ntege, Patricia ^a   Cook, Adrian ^b   Vhembo, Tichaona ^c   Opilo, Wilfred ^d   Namuddu, Rachel ^e   Katuramu, Richard ^a   Tezikyabbiri, Jessica ^d   Naidoo James, Bethany ^b   Gibb, Diana ^b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

^c UNIV OF ZIMBABWE MEDICAL SCHOOL   (Zimbabwe)

^d JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^e MULAGO HOSPITAL   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; BODY WEIGHT; CAREGIVER SUPPORT; CHILD; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MONITORING; DRUG PREFERENCE; EVENING DOSAGE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; PRESCHOOL CHILD; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYRUP; TABLET FORMULATION; TREATMENT DURATION; TREATMENT PLANNING; AFRICA; TABLET;

AFRICA; ANTI-HIV AGENTS; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; MALE; QUESTIONNAIRES; TABLETS;

EID: 84860462198     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036186     Document Type: Article

References (28)

1. Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, et al. (2001) Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS 15: 181-1183.
2. Gross R, Yip B, Lo Re V, Wood E, Alexander CS, et al. (2006) A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis 194: 1108-1114.
3. Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, et al. (2006) Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr 43: 78-84.
4. Sohn A, Ananworanich J, (2007) How can we simplify antiretroviral therapy in children? Curr Opin HIV AIDS 2: 426-430.
5. Havens PL, Gibb DM, (2007) Increasing antiretroviral drug access for children with HIV infection. Pediatrics 119: 838-845 (DOI:10.1542/peds.2007-0273).
6. UNICEF, WHO (2010) Sources and prices of selected medicines for children. April 2010. Accessed November 2 2011 at: http://www.who.int/medicines/publications/essentialmedicines/Sources_Prices2010.pdf.
7. WHO Global Price Reporting Mechanism Transaction prices for antiretroviral medicines and HIV diagnostics from 2008 to October 2009. Accessed November 2 2011 at: http://www.who.int/hiv/amds/GPRMsummaryReportNov2009.pdf.
8. UNICEF, WHO (2004) Improving access to appropriate paediatric ARV formulations. November 2004. Accessed November 2 2011 at: http://www.who.int/3by5/en/finalreport.pdf.
9. Calmy A, Pascual F, Ford N, (2004) First-line and second-line antiretroviral therapy. The Lancet 364 (9431): 329.
10. Gilks CF, Crowley S, Ekpini R, Gove S, Perriens J, et al. (2006) The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. The Lancet 368 (9534): 505-10.
11. Pujari SN, Patel AK, Naik E, Patel KK, Dravid A, et al. (2004) Effectiveness of Generic Fixed-Dose Combinations of Highly Active Antiretroviral Therapy for Treatment of HIV Infection in India. J Acquir Immune Defic Syndr 37 (5): 1566-9.
12. Walker A, Ford D, Mulenga V, Thomason M, Nunn A, et al. (2009) Adherence to Both Cotrimoxazole and Placebo is Associated with Improved Survival Among HIV-Infected Zambian Children. AIDS Behav 13 (1): 33-41.
13. Shingadia D, Viani RM, Yogev R, Binns H, Dankner WM, et al. (2000) Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus. Pediatrics 105: e80 (DOI: 10.1542/peds.105.6.e80).
14. Temple ME, Koranyi KI, Nahata MC, (2001) Gastrostomy tube placement in nonadherent HIV-infected children. Ann Pharmacother 35: 414-418.
15. King JR, Yogev R, Aldrovandi G, Chadwick E, Acosta EP, (2004) Pharmacokinetics of antiretrovirals administered to HIV-infected children via gastrostomy tube. HIV Clin Trials 5: 288-293.
16. Eldridge K, Gallagher J, (2000) Dental caries prevalence and dental health behaviour in HIV infected children. Int J of Paediatr Dent 10: 19-26.
17. WHO (2010) Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach (2010 revision) Geneva, Switzerland WHO.
18. Fillekes Q, Natukunda E, Balungi J, Kendall L, Bwakura-Dangarembizi M, et al. (2011) Paediatric under-dosing of Efavirenz: a pharmacokinetic study in Uganda. J Acquir Immune Defic Syndr 58: 392-398.
19. Kasirye P, Kendall L, Adkison KK, Tumusiime C, Ssenyonga M, et al. (2012) Pharmacokinetics of oral solution versus tablet formulation varies with antiretroviral drug in the target population of HIV-1 infected children. Clinical Pharmacology and Therapeutics 91: 272-280.
20. Musiime V, Kendall L, Bakeera-Kitaka S, Snowden W, Odongo F, et al. (2010) Pharmacokinetics and acceptability of once versus twice daily lamivudine and abacavir in HIV-1 infected Ugandan children in the ARROW trial. Antivir Ther 15 (8): 1115-24.
21. Bagenda A, Kallander K, Barlow-Mosha L, Byogero R, Musoke P, (2010) Caregiver experience with syrup and tablet formulations of HAART for paediatric HIV treatment in an urban clinic [Abstract CDB0228]. In: XVIII International AIDS Conference, 2010, Vienna.
22. Bagenda A, Barlow-Mosha L, Bagenda D, Sakwa R, Fowler MG, et al. (2011) Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda. Ann Trop Paediatr 31: 235-245.
23. Yeung VW, Wong ICK, (2005) When do children convert from liquid antiretroviral to solid formulations? Pharm World Sci 27: 399-402.
24. Garvie PA, Lensing S, Rai SN, (2007) Efficacy of a Pill-Swallowing Training Intervention to Improve Antiretroviral Medication Adherence in Pediatric Patients With HIV/AIDS. Pediatrics 119: e893-e899.
25. Thomson SA, Tuleu C, Wong I, Keady S, Pitt K, et al. (2009) Minitablets: New modality to deliver medicines to preschool-aged children. Pediatrics 123: e235-e238.
26. Livshits Z, Lee S, Hoffman R, Nelson L, Esteban-Cruciani N, (2011) Zidovudine overdose in a healthy newborn receiving postnatal prophylaxis. Clin Toxicol 49: 747-749.
27. Mulenga V, Cook A, Walker AS, Kabamba D, Chijoka C, et al. (2010) Strategies for Nevirapine Initiation in HIV-Infected Children Taking Pediatric Fixed-Dose Combination "Baby Pills" in Zambia: A Randomized Controlled Trial. Clin Infect Dis 51 (9): 1081-1089.
28. Chokephaibulkit K, Plipat N, Cressey T, Frederix K, Phongsamart W, et al. (2005) Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine. AIDS 19: 1495-1499.